ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part Two)
July 09, 2024In recent years, with the deepening of research into the pathogenesis of myelodysplastic syndromes (MDS), many novel drugs have emerged. -
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part one)
July 09, 2024Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies characterized by defective normal hematopoiesis leading to a reduction in blood cells, with a risk of transformation into acute myeloid leukemia. -
Luspatercept Mitigates Anemia in Lower-Risk Myelodysplastic Syndromes
January 20, 2020For patients with lower-risk myelodysplastic syndromes with ring sideroblasts who have been receiving regular red-cell transfusions, luspatercept reduces the severity of anemia compared with placebo ...
Pharma Sources Insight January 2025
